** Shares of 4DMedical 4DX.AX slump as much as 15.7% to
A$0.805, set to see their worst day since April 13 - if losses
hold
** The medical tech co says it has completed a capital
raising of A$35 million ($23.03 million) to partly fund the
acquisition of a U.S.-based medical technology company Imbio
** Issue price of A$0.79 per share is at a 17.3% discount
to the last closing price on Dec 6
** Co says it signed deal to buy Imbio for ~US$25 million to
expand its product portfolio including latter's four FDA-cleared
products
** Stock hits lowest since Nov 24
** Stock has risen more than doubled this year as of last
close
($1 = 1.5198 Australian dollars)
(Reporting by Archishma Iyer)
((Archishma.Iyer@thomsonreuters.com;))